Cargando…
Obstructive sleep apnoea in acute coronary syndrome
Obstructive sleep apnoea (OSA) syndrome affects about 13% of the male and 7–9% of the female population. Hypoxia, oxidative stress and systemic inflammation link OSA and cardiovascular and metabolic consequences, including coronary artery disease. Current research has identified several clinical phe...
Autores principales: | Randerath, Winfried, Bonsignore, Maria R., Herkenrath, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488646/ https://www.ncbi.nlm.nih.gov/pubmed/31366458 http://dx.doi.org/10.1183/16000617.0114-2018 |
Ejemplares similares
-
Sex differences in obstructive sleep apnoea
por: Bonsignore, Maria R., et al.
Publicado: (2019) -
Personalised medicine in sleep respiratory disorders: focus on
obstructive sleep apnoea diagnosis and treatment
por: Bonsignore, Maria R., et al.
Publicado: (2017) -
Evaluation of a multicomponent grading system for obstructive sleep apnoea: the Baveno classification
por: Randerath, Winfried J., et al.
Publicado: (2021) -
Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view
por: Craig, Sonya, et al.
Publicado: (2022) -
Non-sleepy obstructive sleep apnoea: to treat or not to treat?
por: Altintas, Nejat, et al.
Publicado: (2019)